Optimizing the Use of Gene Expression Profiling in Early-Stage Breast Cancer
2016 · Journal of Clinical Oncology · 55 citations
https://doi.org/10.1200/jco.2016.67.7195
M
Martin Rosman
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
31
Papers
682
Citations
15
h-index
16
i10-index
Martin Rosman is an academic researcher from Anne Arundel Medical Center. The author has contributed to research in topics: Breast Cancer Treatment Studies & Breast Lesions and Carcinomas & Breast Implant and Reconstruction. The author has an h-index of 15, co-authored 27 publications.
Papers by this author
worksNormal Axillary Ultrasound Excludes Heavy Nodal Disease Burden in Patients with Breast Cancer
2015 · Annals of Surgical Oncology · 43 citations
https://doi.org/10.1245/s10434-015-4717-7
Is Onco<i>type</i>DX Recurrence Score (RS) of Prognostic Value Once HER2-Positive and. Low-ER Expression Patients are Removed?
2013 · The Breast Journal · 22 citations
https://doi.org/10.1111/tbj.12126
What Is the Value of the 21 Gene Recurrence Score in HER2-Negative Patients?
2010 · Journal of Clinical Oncology · 6 citations
https://doi.org/10.1200/jco.2010.31.2280
The Impact of Genomic Profiling on Adjuvant Therapy Recommendation in Postmenopausal Women with ER-Positive, T1-2 Breast Cancer: Can Genomic Profiling Eliminate the Need for Sentinel Lymph Node Biopsy?
2021 · Clinical Breast Cancer · 4 citations
https://doi.org/10.1016/j.clbc.2021.02.011
Recurrence Score Testing Does not Appear to Benefit Patients With Grade 1, Progesterone Receptor-Positive Breast Cancers
2021 · Hematology/Oncology and Stem Cell Therapy · 2 citations
https://doi.org/10.1016/j.hemonc.2021.05.005
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat